Peptide Therapy: A New Trend Based on Old Science

Peptide Therapy: A New Trend Based on Old Science

Written by Peerawat Kanjanabenja MD.LN 4987 Dr Patrick

Peptide therapy has become a popular topic in wellness, recovery and healthy ageing. It is often presented as a new medical trend, but peptides have been part of medicine for a long time. One of the best-known examples is insulin. Insulin is a peptide hormone that has been used to treat diabetes for more than 100 years. Many well-known GLP-1 medicines, including semaglutide and liraglutide, are also peptide-based. They copy or extend the action of a natural hormone that helps control blood sugar, appetite and digestion.These familiar treatments show that peptide medicine is not new. Today, peptide-based medicines are used for diabetes, obesity, hormone disorders, osteoporosis and some cancers. What is new is the growing interest in other peptides that may support tissue repair, metabolism, physical recovery and healthy ageing.

What are peptides?

Peptides are short chains of amino acids—the same building blocks that form proteins. Many are produced naturally by the body and act as messengers between cells. A simple way to understand peptides is to think of them as biological instructions. Each peptide carries a different message and may guide cells to perform a particular task. Insulin, for example, sends a signal that helps cells take in glucose from the blood.

GLP-1 medicines act like a natural peptide hormone, helping the body manage blood sugar and appetite. Other peptides may influence inflammation, immune activity, energy use or tissue repair. However, peptides are a very diverse group. Just because two substances are both called peptides does not mean they work in the same way or have the same level of scientific evidence.

How do peptides work?

Many peptides attach to specific receptors on the surface of cells, much like a key fitting into a lock. This starts a series of signals inside the cell and may change how the cell behaves. Peptides do not simply “add healing” to the body. Instead, they may guide the body’s existing systems and influence how cells respond to inflammation, stress or injury. With repeated or long-term exposure to certain peptides, cells may sometimes become less sensitive to the signal. Their receptors may respond less strongly or decrease in number. This is known as desensitization or receptor downregulation. This does not happen with every peptide, and it does not mean that all peptide treatments need to be routinely stopped and restarted. However, it shows why the dose, frequency, duration and medical monitoring of treatment may be important.

Peptides receiving attention

BPC-157 and thymosin beta-4 are often discussed in relation to recovery and tissue repair. Early laboratory and animal studies suggest that they may influence inflammation, blood-vessel formation and processes involved in healing Thymosin beta-4 has some human research, especially in skin and eye healing. Evidence for BPC-157 is still mainly based on laboratory and animal studies. Although the two are sometimes used together, there is not yet strong clinical evidence proving the safety or effectiveness of this combination.

MOTS-c is linked to the mitochondria—the structures inside cells that help produce and manage energy. Researchers are studying its possible role in metabolism, glucose control, cellular stress and the body’s response to exercise. The findings are interesting, but most evidence still comes from laboratory and animal research.

GHK-Cu is a naturally occurring peptide that binds to copper. It is commonly found in skincare products and is being studied for its possible effects on collagen, skin quality and wound healing. Evidence for injectable or whole-body use remains more limited than evidence for topical use.

Promise with appropriate caution Insulin and GLP-1 medicines show what well-studied peptide treatments can achieve. However, newer peptides such as BPC-157, MOTS-c and GHK-Cu do not yet have the same level of clinical evidence. Peptides may help support treatment and recovery in selected patients, but they are not a cure-all or a replacement for proven medical care. Product quality, storage, dose, treatment duration and individual health can all affect safety and results.

Peptides can be viewed as sets of biological instructions that guide how the body’s cells communicate and respond. Their potential is exciting, and some may become useful parts of a wider treatment or recovery plan. Their use should always begin with proper medical assessment, reliable products, realistic expectations and appropriate professional supervision.

https://www.taara.clinic/

Comments are closed.